GLP-1 Weight Loss in Burlington, VT: What It Costs and Who Covers It
Burlington's below-state obesity rate, a Vermont Medicaid PDL that excludes weight-loss use outright, and a hospital-only specialist market with no published cash price.
Adult obesity in Burlington is 23.1% (CDC PLACES 2025 release, BRFSS 2023) 1, well below Vermont's statewide 28.8% 2. Chittenden County's seat holds 44,675 residents inside a 229,550-person metro, with a 3.8% uninsured rate and a $71,109 median household income 345.
Burlington is the mandatory Vermont anchor under Astra's all-50-states commitment: Burlington-South Burlington is unambiguously Vermont's largest urban area, with no in-state competing metro of comparable size. The obstacle here is not distance to care. It is that the only specialist pathway in the metro, the University of Vermont Medical Center, publishes no price at all 7.
County
Chittenden County — Vermont's most populous county and home to the state's only academic medical center, the University of Vermont Medical Center. This is not a population-tier pick: Burlington's own city population (44,675) sits below Astra's usual tier-2 band, and its metro (229,550) is roughly a fifth the size of a typical tier-2 metro. Burlington is the mandatory Vermont anchor under Astra's all-50-states commitment (confirmed by the site owner, Aug 27, 2026) — Burlington-South Burlington is unambiguously Vermont's largest urban area, with no in-state competing metro of comparable size.
No county-wide or city-wide geographic Primary Care Health Professional Shortage Area (HPSA) designation covers Burlington or Chittenden County. HRSA's national primary-care HPSA file (BCD_HPSA_FCT_DET_PC.csv, pulled 2026-08-28) shows exactly one Chittenden County match: a facility-specific HPSA for Community Health Centers of Burlington, Inc. (HPSA ID 1509995018, score 8, discipline class Primary Care, designation type Federally Qualified Health Center, designated 5/22/2003, last HRSA update 9/22/2025, designation population 28,908). That designation covers the FQHC's own low-income/underserved patient panel — it is not a finding that Burlington or Chittenden County overall is short on primary care.6
Specialist access
Specialist weight-related care in the Burlington metro runs entirely through the University of Vermont (UVM) Medical Center, Vermont's only academic medical center and largest hospital system. Its bariatric-surgery program office sits at 353 Blair Park Road, Williston, VT (about 9 miles from downtown Burlington); its endocrinology practice, which treats obesity among other conditions, sits at 62 Tilley Drive, Suite 202, South Burlington, VT (about 3 miles away). Both are hospital-affiliated, insurance-billed specialty practices — neither publishes a self-pay or cash price for weight-management or GLP-1 care anywhere on its program page (uvmhealth.org, checked 2026-08-28). Access is real, unlike much of rural Vermont, but it runs entirely through the insurance-billed hospital system, with no price-transparent specialist alternative visible in the city itself.7
Medicaid coverage note
Vermont Medicaid is administered by the Department of Vermont Health Access (DVHA). Its current Preferred Drug List — "Vermont Preferred Drug List and Drugs Requiring Prior Authorization," updated 8/1/2026 (dvha.vermont.gov, PDF fetched 2026-08-28) — sets an explicit policy, not silence. Page 1: drugs used for weight loss are excluded outright from coverage under the Vermont Medicaid Pharmacy program. Page 59: diabetes-labeled GLP-1s (Ozempic, Mounjaro, Trulicity, Victoza, etc.) are covered only with a documented Type 2 diabetes diagnosis. Pages 71-72: Wegovy is covered by prior authorization only for MACE risk reduction (BMI over 27 plus a history of stroke, MI, or symptomatic PAD) or for MASH/NASH with documented liver fibrosis — a listed criterion is that the medication is not being used for weight loss only. Page 238: Zepbound is covered by prior authorization only for diagnosed obstructive sleep apnea (AHI over 15, BMI over 30, already on CPAP). In short: Vermont Medicaid does not cover semaglutide or tirzepatide for weight loss alone, for anyone, at any BMI.89
Vermont Medicaid excludes weight-loss use in writing
Vermont Medicaid is administered by the Department of Vermont Health Access (DVHA). Its current Preferred Drug List, "Vermont Preferred Drug List and Drugs Requiring Prior Authorization," updated 8/1/2026, sets an explicit policy, not silence 89. Page 1 excludes drugs used for weight loss outright from coverage under the Vermont Medicaid Pharmacy program. Page 59 covers diabetes-labeled GLP-1s (Ozempic, Mounjaro, Trulicity, Victoza and others) only with a documented Type 2 diabetes diagnosis 9.
Pages 71 to 72 cover Wegovy by prior authorization only for MACE risk reduction (BMI over 27 plus a history of stroke, MI, or symptomatic PAD) or for MASH/NASH with documented liver fibrosis, with a listed criterion that the medication is not being used for weight loss only. Page 238 covers Zepbound by prior authorization only for diagnosed obstructive sleep apnea (AHI over 15, BMI over 30, already on CPAP) 9. In short: Vermont Medicaid does not cover semaglutide or tirzepatide for weight loss alone, for anyone, at any BMI.
What GLP-1 care costs in Burlington today
There is no local price table to build, because neither Burlington-area option publishes one. UVM Medical Center's Bariatric Surgery Program, at 353 Blair Park Road in Williston about 9 miles from downtown, publishes program and referral information but no self-pay or cash price for weight-management or GLP-1 care. UVM Medical Center's endocrinology practice, at 62 Tilley Drive, Suite 202 in South Burlington about 3 miles out, treats obesity among other endocrine conditions and is insurance-billed only, with no published cash-pay price (uvmhealth.org, checked 2026-08-28) 7.
Astra's price is national and identical in every city it serves: $68/mo for semaglutide and $118/mo for tirzepatide on a 12-month plan ($816 / $1,416 billed annually). Because Burlington's own specialist market publishes no cash price to compare against, that flat published rate is the only verifiable weight-loss-care price point available for Burlington today.
Care exists in Chittenden County, but only through the hospital
No county-wide or city-wide geographic Primary Care Health Professional Shortage Area designation covers Burlington or Chittenden County. HRSA's national primary-care HPSA file (BCD_HPSA_FCT_DET_PC.csv, pulled 2026-08-28) shows exactly one Chittenden County match: a facility-specific HPSA for Community Health Centers of Burlington, Inc. (HPSA ID 1509995018, score 8, discipline class Primary Care, designation type Federally Qualified Health Center, designated 5/22/2003, last HRSA update 9/22/2025, designation population 28,908) 6. That designation covers the FQHC's own low-income and underserved patient panel; it is not a finding that Burlington or Chittenden County overall is short on primary care.
Specialist weight-related care in the metro runs entirely through UVM Medical Center, Vermont's only academic medical center and largest hospital system 7. Access is real, unlike much of rural Vermont, but it runs entirely through the insurance-billed hospital system, with no price-transparent specialist alternative visible in the city itself.
Telehealth changes the shape of that. An Astra consultation is remote, the price is published before a patient starts, and no referral into the Williston or South Burlington clinic is required to find out what treatment costs.
Astra treats patients in Vermont through state-licensed physicians.
Local options
UVM Medical Center — Bariatric Surgery Program — Hospital-affiliated program, 353 Blair Park Road, Williston, VT (~9 mi from downtown Burlington). Publishes program and referral information but no self-pay or cash price for weight-management or GLP-1 care. https://www.uvmhealth.org(checked 2026-08-28)
UVM Medical Center — Endocrinology (South Burlington) — Hospital-affiliated practice, 62 Tilley Drive, Suite 202, South Burlington, VT (~3 mi from downtown Burlington), treats obesity among other endocrine conditions. Insurance-billed only; no published cash-pay price for weight-management or GLP-1 care. https://www.uvmhealth.org(checked 2026-08-28)
Frequently asked questions
How common is obesity in Burlington compared to the rest of Vermont?
CDC PLACES data (2025 release, BRFSS 2023) puts adult obesity in Burlington at 23.1%, well below Vermont's statewide adult obesity rate of 28.8%. Burlington runs lower than the state as a whole, though obesity still affects roughly one in four adults in the city.
Does Vermont Medicaid cover Ozempic, Wegovy, or Zepbound for weight loss?
Not for weight loss alone. Vermont Medicaid's Preferred Drug List (DVHA, updated 8/1/2026) excludes weight-loss-only use outright. Diabetes-labeled GLP-1s are covered only with a Type 2 diabetes diagnosis; Wegovy only for cardiovascular risk reduction or MASH/NASH with liver fibrosis; Zepbound only for diagnosed obstructive sleep apnea. All require prior authorization.
Where can I see a weight-loss specialist in Burlington?
The only specialist pathway in the metro is UVM Medical Center's bariatric-surgery program in Williston and its endocrinology practice in South Burlington. Both treat obesity but are hospital-affiliated, insurance-billed practices with no published cash-pay price for weight-management or GLP-1 care.
Is Astra cheaper in Burlington?
Astra's price is the same everywhere: $68/mo for semaglutide and $118/mo for tirzepatide on a 12-month plan ($816 / $1,416 billed annually), regardless of city or state. Burlington's own specialist market publishes no cash price to compare against, so Astra's flat, published national rate is the only verifiable weight-loss-care price point available for Burlington today.
Is Astra available to patients in Burlington and the rest of Vermont?
Yes. Astra is licensed to treat patients in all 50 states, including Vermont, entirely online.